GoodRx Launches New "Prescription Cost Tracker" to Spotlight Key Factors Driving Out-of-Pocket Medication Costs in the U.S.

Consumers have paid $21 billion out-of-pocket on prescription medications in 2024, an average of $16.26 per prescription Today, GoodRx (NASDAQ:GDRX), the leading prescription savings platform in the U.S., debuted its

BusinesswireJun 26 21:00

This GoodRx Holdings Insider Increased Their Holding In The Last Year

Looking at GoodRx Holdings, Inc.'s (NASDAQ:GDRX ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders tha

Simply Wall StJun 20 02:53

TD Cowen Maintains GoodRx(GDRX.US) With Buy Rating, Maintains Target Price $16

TD Cowen analyst Charles Rhyee maintains $GoodRx(GDRX.US)$ with a buy rating, and maintains the target price at $16.According to TipRanks data, the analyst has a success rate of 47.4% and a total aver

Futu NewsJun 10 19:31 · Ratings

Morgan Stanley Maintains GoodRx(GDRX.US) With Hold Rating, Raises Target Price to $9.5

Morgan Stanley analyst Craig Hettenbach maintains $GoodRx(GDRX.US)$ with a hold rating, and adjusts the target price from $7 to $9.5.According to TipRanks data, the analyst has a success rate of 60.3%

Futu NewsJun 10 18:32 · Ratings

Express News | GoodRx Holdings Inc. : Morgan Stanley Raises Target Price to $9.50 From $7.00

BreakingsJun 10 18:29

Morgan Stanley Maintains Equal-Weight on GoodRx Holdings, Raises Price Target to $9.5

Morgan Stanley analyst Craig Hettenbach maintains GoodRx Holdings with a Equal-Weight and raises the price target from $7 to $9.5.

Analyst UpgradesJun 10 17:35